ASX ANNOUNCEMENT/MEDIA RELEASE 19 AUGUST 2026 AROA BIOSURGERY LIMITED ARBN 638 867 473 NZCN 1980577 64 Richard Pearse Drive, Auckland 2022, New Zealand AROA.COM R E S U L T S O F A N N U A L G E N E R A L M E E T I N G Soft tissue regeneration company Aroa...
Aroa Biosurgery: Results of Annual General Meeting
Filed with ASX · · 2 pages · English
Release
In the deck
Story so far
Earlier from Aroa Biosurgery
- CEO Presentation - AGM
- Chairman's Address - AGM
- Notification of cessation of securities - ARX
- Notification regarding unquoted securities - ARX
- Change in substantial shareholding for ARX
Later from Aroa Biosurgery
- Final Director's Interest Notice - JD
- Change of Director's Interest Notice - BW
- Myriad MASTRR Study Reports Low Infection Rates
- Peer-reviewed 411-patient study reports low infection rates with Myriad™ in complex soft tissue reconstruction
- Invite to Investor Webinar on MASTRR Interim Analysis
Follow Aroa Biosurgery into a list and get an email when it puts out news.
Follow Aroa Biosurgery